Solomon Gedfie

Solomon Gedfie

Auto-generated profile, based on publicly available information

Solomon Gedfie

College of Health Sciences, Woldia University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Global Pediatric Health
Verified
Journal Article
Open access
SGSolomon Gedfie
Solomon Gedfie
SGSolomon Getawa
Solomon Getawa
MMMulugeta Melku
Mulugeta Melku
Background. Iron deficiency anemia is a common health problem that affects children under the age of five. Children’s cognitive performance is impaired by iron deficiency, which impacts their psychomotor development. Therefore, the aim of this study was to determine the global prevalence and associated factors of iron deficiency and iron deficiency anemia among under-5 children. Methods. Relevant publications published till March 30, 2021 were identified in databases such as Medline/PubMed, Science Direct, Popline, EMBASE, African Journals Online, Scopus, and Google Scholar. The STATA version 11 software was utilized for the analysis. To determine the level of heterogeneity, I2 test statistics were used. To detect publication bias, funnel plots analysis and the Egger weighted regression test were used. Results. The global pooled prevalence of iron deficiency anemia and iron deficiency was 16.42% (95% CI: 10.82, 22.01) and 17.95% (95% CI: 13.49, 22.41), respectively. Age less than 2 years (OR = 1.26; 95% CI: 1.14, 1.38) and living in a large family size (OR = 1.38; 95% CI: 1.18, 1.58) were associated with iron deficiency anemia. Children born from anemic mother, low birth weight, and do not drink iron fortified milk (OR = 1.20; 95% CI: 1.05, 1.36), (OR = 1.15; 95% CI: 1.01, 1.36) and (OR = 1.28; 95% CI: 1.10, 1.46), respectively were associated factors of iron deficiency in under-5 children. Conclusion. The prevalence of iron deficiency anemia and iron deficiency was significant across the globe, particularly in Asia and Africa. Therefore, regular screening and treatment of iron deficiency and iron deficiency anemia are required especially in high-risk children to reduce their complication. PROSPERO registration number: CRD42021267060

29 August 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Melese Abate RetaMelese Abate Reta
Melese Abate Reta
ZAZelalem Asmare
Zelalem Asmare
ASAssefa Sisay
Assefa Sisay
YGYalewayker Gashaw
Yalewayker Gashaw
EGErmias Getachew
Ermias Getachew
PFP. Bernard Fourie
P. Bernard Fourie
Background: Despite the decline in tuberculosis (TB) incidence across many regions worldwide, including Ethiopia, the disease remains highly concentrated among vulnerable or socially marginalized populations and in high-risk settings. This systematic review and meta-analysis aims to estimate the pooled prevalence of pulmonary tuberculosis (PTB) among key and vulnerable populations (KVPs) residing in hotspot settings in Ethiopia. Methods: Potential papers were searched systematically in PubMed, Scopus, ScienceDirect databases, Google Scholar search engine, and institutional electronic repositories/registrars. A total of 34 potential articles that provide necessary information on the prevalence of PTB were reviewed and data were analyzed to determine the pooled prevalence of PTB among KVPs. The relevant data were recorded and analyzed using STATA 17.0. Cohen’s kappa was computed to determine the agreement between reviewers, the Inverse of variance (I2) to evaluate heterogeneity across studies, and Egger’s test to identify publication bias. A random effect model was used to determine the pooled prevalence of PTB, subgroup analysis was computed by types of hotspot settings and year of publication. Results: This meta-analysis demonstrates that the pooled prevalence of PTB among populations residing in hotspot settings in Ethiopia was 11.7% (95% confidence interval (95CI): 7.97–15.43) with an I2 of 99.91% and a p< 0.001. Furthermore, the subgroup analysis unveiled the pooled prevalence of PTB among KVPs residing in different hotspot settings as follows: Prison inmates 8.8% (95CI: 5.00–12.55%), University students 23.1% (95CI: 15.81–30.37%), Refugees 28.4% (95CI: -1.27–58.15%), Homeless peoples 5.8% (95CI: -0.67–12.35%), Healthcare settings 11.1% (95CI: 0.58–21.63%), Spiritual holy water sites attendees 12.3% (95CI: -6.26–30.80%), and other high-risk settings 4.3% (95CI: 0.47–8.09%). Besides, the subgroup analysis revealed that the pooled prevalence of PTB post-2015 was 10.79% (95CI: 5.94–15.64%), whereas it stood at 14.04% (95CI: 10.27–17.82%) before 2015. Conclusion: The prevalence of PTB among KVPs residing in the hotspot settings in Ethiopia remains significant, with a weighted pooled prevalence of 11.7%. Thus, the national TB control programs should give due attention and appropriate control measures should be instituted that include regular systematic TB screening, compulsory TB testing for presumptive TB cases among KVPs, and tightened infection control at hotspot settings.

8 November 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SGSolomon Gedfie
Solomon Gedfie
SGSolomon Getawa
Solomon Getawa
Woldeteklehaymanot KassahunWoldeteklehaymanot Kassahun
Woldeteklehaymanot Kassahun
KGKiros Terefe Gashaye
Kiros Terefe Gashaye
MMMulugeta Melku
Mulugeta Melku
More than one-third of reproductive aged women in Ethiopia use hormonal contraceptives to prevent conception. The present study aimed to compare the hematological parameters of reproductive-age women taking hormonal contraceptives at the University of Gondar Comprehensive Specialized Referral Hospital, Northwest Ethiopia in 2021. A comparative cross-sectional study was conducted from April to June 2021. A total of 240 study participants were recruited by using a consecutive sampling technique. Data on socio-demographic variables and clinical data were collected through face-to-face interviews using a structured questionnaire and medical record reviews, respectively. Three milliliter venous blood was collected for complete blood count analysis using Unicel DxH 800 coulter hematology analyzer. Data was entered into Epi-data 4.4.3.1 version then exported to IBM SPSS v25 for analysis. Kruskal-Wallis H, Dunn-Bonferroni pairwise comparison test, and Spearman’s correlation analysis were used for inferential statistics. P<0.05 were considered statistically significant. The median and interquartile range of platelet count among combined oral contraceptive users was 285(238–332) which is significantly higher than that of depot medroxyprogesterone acetate users 246(220–226) (p = 0.010), implant user 247(221–297) (p = 0.034), and controls 256(224–278) (p = 0.015). The result also showed long-term use of implant negatively correlated with red blood cell count (p = 0.033). This finding concludes that combined oral contraceptive users had a higher platelet counts than controls while long-term use of implants can result in low red blood cells count. Therefore, a baseline evaluation of complete blood count in women desiring contraceptive methods would also be recommended.

3 August 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SGSolomon Gedfie
Solomon Gedfie
Melese Abate RetaMelese Abate Reta
Melese Abate Reta
MGMuluken Gashaw
Muluken Gashaw
ABAlembante Bazezew
Alembante Bazezew
AJAbdu Jemal
Abdu Jemal
WKWoldeteklehaymanot Kassahun
Woldeteklehaymanot Kassahun
Background: Leukemia is a group of diverse and biologically distinct blood cancers. While progress has been made in combating infectious diseases, chronic diseases like leukemia are increasingly prevalent. Current data on leukemia’s prevalence in Africa are inconsistent, necessitating a comprehensive systematic review. This study aims to determine the pooled prevalence and associated risk factors of leukemia across Africa through a systematic review and meta-analysis. Method: This systematic review and meta-analysis were conducted based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A comprehensive literature search was conducted across multiple databases, including PubMed/MEDLINE, Scopus, and Science Direct, supplemented by searches using the Google Scholar and manual searches to identify eligible studies. Statistical analysis was performed using STATA version 11, with a random-effects model employed to compute pooled estimates. Higgen’s I 2 test statistics and meta-regression was conducted to explore potential sources of heterogeneity. Publication bias was assessed visually by Funnel plots and statistically using Egger’s weighted regression test, a p-value of less than 0.05 indicates the presence of significant publication bias. Results: A total of 17,546 articles were retrieved, of which fifteen studies, which recruited 42,884 individuals, were included in the meta-analysis. The pooled prevalence of leukemia was 5.09% (95% CI: 4.02, 6.17) with I 2 of 97.1%. Due to the heterogeneity, subgroup analyses by country showed that the highest prevalence was 10.58% in Nigeria, and the lowest was 0.58% in Zambia. Subgroup analysis based on publication year revealed 4.16% among studies conducted before 2015 and 6.67% among studies conducted after 2016. Additionally subgroup by sample size showed: smaller sample sizes (<384 participants) yielded a higher pooled estimate of 7.99%, conversely, studies with larger sample sizes (≥385 participants) showed 3.61%. Whereas subgroup analysis by population showed that 3.38% in children and 7.15% in the general population. Among the factors identified, rural residency (OR: 56.98, 95% CI: 9.97–326.70) and older age (OR: 3.90, 95% CI: 1.39–10.98) were significant predictors of leukemia in Africa. Conclusion: This review reveals a pooled prevalence of 5.09%, with rural residency and older age identified as significant predictors of leukemia in Africa, underscoring a public health concern.

5 October 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SGSolomon Gedfie
Solomon Gedfie
MGMuluken Gashaw
Muluken Gashaw
AAAbebe Adisu
Abebe Adisu
ABAlembante Bazezew
Alembante Bazezew
AJAbdu Jemal
Abdu Jemal
WKWoldeteklehaymanot Kassahun
Woldeteklehaymanot Kassahun
Background: Attention-deficit/hyperactivity disorder (ADHD) is a common childhood neurodevelopmental disorder of uncertain etiology. Iron is crucial for brain function and dopamine regulation, but prior studies examining its association with ADHD have produced inconsistent results. This systematic review and meta-analysis aimed to compare serum ferritin concentrations in children with ADHD versus healthy controls. Method: This systematic review and meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A comprehensive literature search was conducted across PubMed/MEDLINE, Scopus, Science Direct, and Google Scholar to identify eligible studies. Statistical analyses were performed using STATA version 17, and a random-effects model was applied to estimate the pooled mean difference (MD) and standardized mean difference (SMD). Heterogeneity across included studies was assessed using Higgins’ I 2 test. Publication bias was evaluated visually using funnel plots and statistically via Egger’s weighted regression test. Results: A total of 7643 articles were identified, of which 21 studies (including 4,058 ADHD cases and 4,533 controls) were included in the final meta-analysis. The pooled mean difference (MD) in serum ferritin levels between children with ADHD and healthy controls was −9.74 (95% CI: −16.50, −2.98). Subgroup analyses were conducted to explore heterogeneity. By continent, the highest pooled MD was observed in Africa (−19.28, 95% CI: −40.73, 2.17) and the lowest in North America (−1.42, 95% CI: −6.98, 4.13). By publication year, studies published before 2015 showed a pooled MD of −1.94 (95% CI: −2.31, −1.58), compared to −19.43 (95% CI: −34.37, −4.49) for those published after 2016. By sample size, smaller studies (<199 participants) yielded a higher MD (−12.12, 95% CI: −21.91, −2.34) than larger studies (≥200 participants; −7.64, 95% CI: −17.33, 2.05). By study design, the pooled MD was −1.95 (95% CI: −2.31, −1.59) for case-control studies and −14.85 (95% CI: −27.07, −2.63) for comparative cross-sectional studies. In the subgroup analysis based on ADHD diagnostic criteria, the DSM-IV-TR criteria yielded the largest mean difference (−16.56, 95% CI: −28.23, −4.89). Conclusion: Lower serum ferritin levels (pooled MD: −9.74) are associated with ADHD in children. Accordingly, screening for serum ferritin and enhanced iron supplementation should be considered in this population. Future longitudinal studies are needed to clarify the causal relationship between iron deficiency and ADHD severity.